agilon health, inc. Other Comprehensive Income (Loss), Net of Tax
agilon health, inc. (AGL) reported Other Comprehensive Income (Loss), Net of Tax of -$325.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-05
- agilon health, inc. other comprehensive income (loss), net of tax for the quarter ending 2026-06-30 was -$325.00K, a 233.20% decline year-over-year.
- agilon health, inc. other comprehensive income (loss), net of tax for the quarter ending 2026-03-31 was -$437.00K, a 169.26% decline year-over-year.
- agilon health, inc. other comprehensive income (loss), net of tax for the quarter ending 2025-12-31 was $36.00K.
- agilon health, inc. other comprehensive income (loss), net of tax for the quarter ending 2025-09-30 was $93.00K, a 96.62% decline year-over-year.
- agilon health, inc. other comprehensive income (loss), net of tax for fiscal 2025 was $1.00M, a 54.57% decline from fiscal 2024.
- agilon health, inc. other comprehensive income (loss), net of tax for fiscal 2024 was $2.21M, a 32.25% decline from fiscal 2023.
- agilon health, inc. other comprehensive income (loss), net of tax for fiscal 2023 was $3.26M.
- agilon health, inc. other comprehensive income (loss), net of tax for fiscal 2022 was -$5.56M.
| Period end | Other Comprehensive Income (Loss), Net of Tax 3 month | Other Comprehensive Income (Loss), Net of Tax 6 month | Other Comprehensive Income (Loss), Net of Tax 9 month | Other Comprehensive Income (Loss), Net of Tax 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$325.00K 10-Q · filed 2026-08-05 | -$762.00K 10-Q · filed 2026-08-05 | -$726.00K derived: sum of 3 quarters · filed 2026-08-05 | -$633.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | -$437.00K 10-Q · filed 2026-05-06 | -$401.00K derived: sum of 2 quarters · filed 2026-05-06 | -$308.00K derived: sum of 3 quarters · filed 2026-05-06 | -$64.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $36.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $129.00K derived: sum of 2 quarters · filed 2026-02-25 | $373.00K derived: sum of 3 quarters · filed 2026-08-05 | $1.00M 10-K · filed 2026-02-25 |
| 2025-09-30 | $93.00K 10-Q · filed 2025-11-04 | $337.00K derived: sum of 2 quarters · filed 2026-08-05 | $968.00K 10-Q · filed 2025-11-04 | $579.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $244.00K 10-Q · filed 2026-08-05 | $875.00K 10-Q · filed 2026-08-05 | $486.00K derived: sum of 3 quarters · filed 2026-08-05 | $3.23M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $631.00K 10-Q · filed 2026-05-06 | $242.00K derived: sum of 2 quarters · filed 2026-05-06 | $2.99M derived: sum of 3 quarters · filed 2026-05-06 | $3.29M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | -$389.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $2.36M derived: sum of 2 quarters · filed 2026-02-25 | $2.66M derived: sum of 3 quarters · filed 2026-02-25 | $2.21M 10-K · filed 2026-02-25 |
| 2024-09-30 | $2.75M 10-Q · filed 2025-11-04 | $3.05M derived: sum of 2 quarters · filed 2025-11-04 | $2.60M 10-Q · filed 2025-11-04 | $6.53M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | $300.00K 10-Q · filed 2025-08-04 | -$149.00K 10-Q · filed 2025-08-04 | $3.78M derived: sum of 3 quarters · filed 2026-02-25 | $3.92M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | -$449.00K 10-Q · filed 2025-05-06 | $3.48M derived: sum of 2 quarters · filed 2026-02-25 | $3.62M derived: sum of 3 quarters · filed 2026-02-25 | $802.00K derived: sum of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | $3.93M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $4.07M derived: sum of 2 quarters · filed 2026-02-25 | $1.25M derived: sum of 3 quarters · filed 2026-02-25 | $3.26M 10-K · filed 2026-02-25 |
| 2023-09-30 | $139.00K 10-Q · filed 2024-11-07 | -$2.68M derived: sum of 2 quarters · filed 2024-11-07 | -$670.00K 10-Q · filed 2024-11-07 | -$1.13M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-06-30 | -$2.82M 10-Q · filed 2024-08-06 | -$809.00K 10-Q · filed 2024-08-06 | -$1.27M derived: sum of 3 quarters · filed 2025-02-25 | -$6.88M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-03-31 | $2.01M 10-Q · filed 2024-05-07 | $1.55M derived: sum of 2 quarters · filed 2025-02-25 | -$4.06M derived: sum of 3 quarters · filed 2025-02-25 | -$3.55M derived: sum of 4 quarters · filed 2025-02-25 |
| 2022-12-31 | -$462.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | -$6.07M derived: sum of 2 quarters · filed 2025-02-25 | -$5.56M derived: sum of 3 quarters · filed 2025-02-25 | -$5.56M 10-K · filed 2025-02-25 |
| 2022-09-30 | -$5.61M 10-Q · filed 2023-11-02 | -$5.10M derived: sum of 2 quarters · filed 2023-11-02 | -$5.10M 10-Q · filed 2023-11-02 | |
| 2022-06-30 | $513.00K 10-Q · filed 2023-08-03 | $513.00K 10-Q · filed 2023-08-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |